Maximizing dendritic cell migration in cancer immunotherapy - Wikidata - wikimedia - TriplyDB

Maximizing dendritic cell migration in cancer immunotherapy

Maximizing dendritic cell migration in cancer immunotherapy

http://www.wikidata.org/entity/Q58619973

about

Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation Dendritic cell-based vaccine efficacy: aiming for hot spots Generation of recombinant antibody fragments that target canine dendritic cells by phage display technology.Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging.Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4 Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine.Tracking dendritic cell migration into lymph nodes by using a novel PET probe 18F-tetrafluoroborate for sodium/iodide symporter.In vitro end points for the assessment of cellular immune response-modulating drugs.Taking the lymphatic route: dendritic cell migration to draining lymph nodes.Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination.In-chip fabrication of free-form 3D constructs for directed cell migration analysis.A large-scale 19F MRI-based cell migration assay to optimize cell therapy

P2860

Q27349546-36A07B91-8B5D-4DA6-BE07-E3B0565B8FB6 Q28082680-B5B15F00-749E-4FE1-B891-1EE56B2EF67E Q33994982-93B056B4-242A-44BE-841A-37B2688A7A7E Q34216061-76AA8B48-0689-4BC6-9E81-8A83E498586B Q34892779-FAC60833-A3BA-40F4-BEF0-88284F65C604 Q36800386-85B95885-BD2E-4C44-85FB-654C9D5FA2F5 Q37686631-106A5E88-6B6E-42A3-B123-D8D896C9978F Q37737503-6953A54B-6FC0-4FA7-BD0B-F7185386D078 Q38088820-5E2F2419-78EC-4519-AFF6-80E2E7BF3BC4 Q38176818-920FF89E-AA9A-4B29-8335-5092A65180E3 Q42969701-60B129E7-B6C8-46AC-AE12-E7A57CD92229 Q51527190-30C9C8CF-E7E0-4474-8B80-823A637BF5A7 Q58619881-D7AA0659-FECF-45AA-A2B9-0812220B3AF4

P2860

Maximizing dendritic cell migration in cancer immunotherapy

http://www.wikidata.org/entity/Q58619973

description

im Juli 2008 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 July 2008

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2008

@uk

name

Maximizing dendritic cell migration in cancer immunotherapy

@en

Maximizing dendritic cell migration in cancer immunotherapy

@nl

type

label

Maximizing dendritic cell migration in cancer immunotherapy

@en

Maximizing dendritic cell migration in cancer immunotherapy

@nl

prefLabel

Maximizing dendritic cell migration in cancer immunotherapy

@en

Maximizing dendritic cell migration in cancer immunotherapy

@nl

P1433

Q58619973-2F2BCEDA-1745-4F7B-A21D-786E37E77DD6

P1476

Q58619973-32318615-0C18-4D5B-BC79-84F2FCD46B62

P2093

Q58619973-0A820AF5-22F2-42D2-A308-492DB2EDB79D

Q58619973-4F0E3008-F554-430D-8150-C918F98B2F0C

Q58619973-83DB2634-6537-46C7-8CEC-7A9C7D2B41E2

P2860

Q58619973-00D66180-848C-425F-A7B3-A222DF430E82

Q58619973-0A281E81-46C3-4AD8-87B2-59B282B33007

Q58619973-17D68097-8262-4387-8EA5-1EC7A55649A4

Q58619973-1954EC64-4399-4C76-8E6E-60F02A7B787E

Q58619973-22926AF1-8783-4768-BDF1-BE09C5687B93

Q58619973-25809221-0EDD-40C3-8FAC-A3AF5E0025AA

Q58619973-26D96C32-9803-4C37-83CE-10E01E8930F2

Q58619973-275ACF11-3866-4CE1-AF95-3EB20F89A83C

Q58619973-279EEB03-F1C6-473F-9ACA-E47C284FCE73

Q58619973-28B5B657-EB3E-4202-8114-874FB0883DBC

P304

Q58619973-2E2A2A1F-6D87-4F1A-9E75-1D3E920C6648

P31

Q58619973-E57868B0-CF14-4380-991D-B010215A808F

P356

Q58619973-98E610EA-5367-47C4-BA2E-AF5D649B7D70

P407

Q58619973-ABD1924C-B2E2-43A7-98DC-919609AE0E58

P433

Q58619973-B3415493-B12F-48DF-864F-97189012E334

P478

Q58619973-AAAD42F2-37FF-4773-9AB2-593A77D4F078

P50

Q58619973-1E807EFA-299B-4B31-9223-255BD94AE24F

Q58619973-5D890A88-847F-4309-B1A8-372AC1A5A82E

P577

Q58619973-034C57B0-5F6F-40EB-9A19-88E769540E03

P698

Q58619973-EE6760ED-1B43-4149-9E72-5925A202E708

P921

Q58619973-0EC6D82A-0DC5-4D11-9859-5A344D9B0925

P356

14712598.8.7.865

P1433

Expert Opinion on Biological Therapy

P1476

Maximizing dendritic cell migration in cancer immunotherapy

@en

P2093

Cornelis J A Punt

http://www.w3.org/2001/XMLSchema#string

Erik H J G Aarntzen

http://www.w3.org/2001/XMLSchema#string

I Jolanda M de Vries

http://www.w3.org/2001/XMLSchema#string

P2860

CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2

Evaluation of in vivo labelled dendritic cell migration in cancer patients

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.

Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells.

Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients.

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Dendritic cell immunotherapy: mapping the way.

Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity.

The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.

P304

865-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.8.7.865

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Pauline Verdijk

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18549318

http://www.w3.org/2001/XMLSchema#string

P921